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Abstract:  
This study reports for the first time a detailed experimental investigation of protein crystallization in 
engineered nano-confined spaces with both controlled pore diameters and narrow pore size 
distributions. We propose a systematic approach for controlling the nucleation and crystallization of 
biological macromolecules based on a relationship between the protein radius of gyration (Rg) and 
specific pore diameter. A series of nano-nucleants with ordered mesopores having narrow pore size 
distributions were prepared. The templates were tested for proteins ranging in molecular weight from 
14kDa to 450kDa. Well formed protein crystals were obtained on only one of the five presented nano-
nucleants for all protein cases tested, highlighting the unique template selectivity exhibited by these 
nucleants. In addition, Concanavalin A and Catalase were both crystallized at ∼2 times lower super-
saturation levels than previously reported by any known method. Our observations fully support 
theoretical studies which predict the enhanced thermodynamic stability of proteins in nanoconfined 
cavities, including specifically the importance of nucleant pore diameter with respect to protein radius 
of gyration.  The nucleants described here could have major industrial applications for downstream 
separation and purification of biopharmaceuticals, as well as improved opportunities for the 
crystallization of complex proteins for structural determination.  
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Introduction:
A key element for the successful structure determination of proteins depends on obtaining protein 
single crystals of good diffraction quality1,2.  Even after 150 years of extensive research, obtaining 
diffraction quality macromolecular crystals remains more art than science, and is generally accepted to 
be the major bottleneck in the progress of molecular biology and its therapeutic applications3.   Recent 
statistics obtained from the Protein Expression Purification and Crystallization Database (PepcDB) are 
concerning. They report only an overall ∼2% success rate from protein cloning to successful structure 
determination (i.e. out of more than 180,000 proteins cloned, ∼ 4500 structures have been solved).   
Another reason for an increasing interest in protein crystallization is as an alternate to 
chromatographic separation methods, which currently forms the backbone of the biopharmaceuticals 
manufacturing process4. The main reason for this interest are close aligned to the fact that ∼80% of final 
biopharmaceutical production costs are currently associated with downstream processing, which means 
specifically chromatography related costs.  Our societal need to produce new biopharmaceuticals which 
are both efficacious and affordable necessitates a need to evaluate other lower cost protein purification 
and separation processes such as crystallization. 
Nucleation is the first step of any crystallization process.  Crystal formation from solution is a first 
order phase transition, which starts with nucleation.  Nucleation is considered pivotal not only in 
inducing crystallization but also in controlling crystal quality5. Once the nucleus is formed, it optimally 
grows in metastable conditions, which are energetically unfavorable for forming new stable nuclei.  
Nucleation under metastable conditions can be obtained and controlled by providing energetically 
favorable sites (seeds or other surfaces), which can lower the energy barrier required to form nuclei and 
obtain controlled heterogeneous crystallization6. The search for suitable materials which can induce and 
control nucleation of a wide variety of proteins, has been ongoing for over 30 years and a variety of 
approaches have been used to promote and control nucleation to obtain diffraction quality protein 
crystals7-15. These approaches include the effects of epitaxy, surface morphology, disordered porosity, 
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surface roughness and surface chemistry, as well as the use of various crystalline and amorphous 
miscellaneous material7,10,11,13,16-20. This work has offered little in terms of systematic methodological 
understanding, and most studies have been highly empirical in their approach. Nevertheless these 
materials have exhibited some limited successes for selected systems, though most of these studies have 
offered a very limited theoretical insight into the reasons for success, or failure, of the nucleants 
deployed.  
Numerous porous solid state materials (porous silicon, bioactive glasses, mesoporous gold and porous 
glasses) with broad pore size distributions, as well as disordered pore shapes and structures, have been 
reported to be successful substrates for crystallizing different proteins.  These materials have been 
promoted as potential candidates for use as universal nucleants. The wide range of pore sizes offered by 
these materials are argued to suit a wide range of proteins due to the different critical nucleus sizes 
exhibited by different proteins 2,21. Indeed it is argued that the lack of selectivity exhibited by these 
materials is one of their primary benefits. It has been previously reported that surfaces with narrow pore 
size distributions and structured pore arrangement failed to influence nucleation and 
crystallization16,22,23.  This could be due to inappropriate pore size range or chemistry of the substrate 
used. Very recently proteins to be crystallized were used as templates to imprint polymers, and these 
molecularly imprinted polymers were then used to crystallize a range of proteins. However, this work 
though interesting, does not provide a robust method which can be used to crystallize proteins reliably 
for a wide range of molecular weights, as during imprinting it is very difficult to control the aggregation 
and unfolding of the proteins24.    
A number of researchers using simulations and models have theoretically predicted the solution 
behavior of selected proteins in nano-confined spaces. Wu et al. have reported that proteins constrained 
within nano-size cylinders exhibited much higher rates of protein folding and improved thermodynamic 
stability as reflected in their folding temperatures25. This enhanced folding rate is driven by the 
geometrical restriction in the conformation space for the protein molecule, with protein stability 
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increasing as the pore diameter decreases and approaches twice Rg for the proteins in question. Zhang 
and Cheung have modeled protein confinement in spherical and ellipsoidal nano-spaces26. They also 
reported enhanced levels of protein folding and protein thermodynamic stability, with folding 
temperatures increased by 70K for pores sizes equal to twice Rg compared to the bulk conditions. Their 
analysis assumed repulsive interactions between the pore wall and the protein. Mittal and Best have also 
modeled  protein confinement and have produced a number of scaling laws for protein stability versus 
confinement dimensions27. Again optimal conditions for stability and folding occur as the confinement 
dimensions approach twice Rg. Whilst the relationship between protein confinement in nano-cavities 
and protein nucleation phenomena is complex and not currently fully understood, it is a reasonable 
assumption that any process which facilitates the formation of the thermodynamically most stable state 
protein solution conformation which could be expected to facilitate the overall process of protein 
nucleation. 
No previous experimental study has systematically investigated the influence of surface templates 
with narrow pore size distributions for controlling nucleation and crystallization of biological 
macromolecules. The current study seeks to understand the heterogeneous crystallization of specific 
protein molecules on surfaces with controlled pore diameters, and in doing so establish a correlation 
between pore diameter and protein solution properties. Such an understanding would allow the 
development of new systematic methods for crystallization of specific biological macromolecules. 
 
Methods: 
Synthesis and Characterization of Mesoporous Glasses: 
In order to engineer pores in the pore diameter size range 3-4nm, templates were synthesized using sol-
gel based methods reported in the literature28.  Different volumetric ratios of DI water and the silica 
precursor (tetraethyl ortho-silicate (TEOS)) as well as catalyst and TEOS were used to prepare different 
materials.  To synthesize the material with larger pore diameters with an ordered structure, two different 
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sacrificial templates (tri-block copolymer surfactants Pluronic F127 & Pluronic P123) were used. The 
synthesis conditions used here were based on the recipe reported earlier in the literature29,30.  Details of 
synthesis are described in Supporting Information. 
The material synthesized was characterized by employing N2 sorption based Brunauer–Emmett–
Teller (BET) and Barrett–Joyner-Halenda (BJH)/ Kelvin equations for the specific surface area and pore 
size distribution respectively31,32. Transmission electron microscope was also used to qualitatively 
observe the pore diameter and the pore structure arrangement.   Details of characterization are described 
in Supporting Information. 
 
Crystallization of Proteins: 
The hanging drop vapor diffusion method was used for the crystallization of proteins on the 
mesoporous templates.  A mesoporous glass template particle was added to the droplet.    Seven different 
model proteins were used for crystallization experiments.  The metastable crystallization conditions for 
each of the proteins were obtained from literature and further optimized experimentally16.  Details of 
these optimized crystallization conditions used are listed in Table 4. Protein crystallization details are 
further described in Supporting Information 
The qualitative observation of crystallization process was carried out using the Olympus BX51M 
reflective microscope (Olympus UK Ltd., UK), which is equipped with the Olympus DP70 digital 
camera (Olympus UK Ltd., UK) for digital imaging.  Single crystal X-ray diffraction data collection the 
protein crystals were obtained using a Rigaku Single Crystal X-ray Diffractometer. Details of 
characterization are described in Supporting Information. 
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Results: 
Preparation of Mesoporous Glass Surfaces: 
Mesoporous glasses with pore sizes < 4nm were synthesized using sol-gel based methods.  To 
synthesize materials with higher pore diameters and ordered structures, two different sacrificial 
templates processes were used with tri-block copolymer surfactants (Pluronic F127 & Pluronic P123).  
Different acid based catalysts were also deployed to optimize surface porosity. Mesoporous template 
surfaces with five different pore diameter ranges were prepared namely, Type-I, II, III, IV, V which have 
pore diameters of 3-4nm, 6-8nm, 10-12nm, 13-15nm and 17-21nm respectively. Table 1 presents the 
physical properties of the templates and Figure 1 shows the pore size distributions of the same templates 
based on Nitrogen isotherms (Barrett–Joyner-Halenda/ Kelvin equation based method32). Transmission 
Electron Micrographs of the corresponding materials are shown in Figure 2.  It is evident from the 
results shown here that the mesoporous templates used in this study have narrow pore size distributions 
and exhibit highly ordered pore structures.   
 
Effect of Nucleant Surface Porosity on Protein Crystallization: 
The crystallization of seven different proteins ranging in molecular weight from 14kDa to 450kDa 
were carried out using mesoporous glass surfaces with five different pore size ranges i.e. 3-4nm, 6-8nm,  
10-12nm, 13-15nm, 17-21nm and a clean non-porous bare glass slide, which was used as the control 
surface.  Figure 3 presents the qualitative results to highlight the effect of specific nucleant porosity on 
crystallization of selective protein molecule, whereas Table 2 shows the results of the experiments 
performed under reported metastable conditions.  Details of crystallization experimental observations are 
reported below.   
Lysozyme: Crystals of lysozyme was observed within 12-24 hours on surfaces with pore diameter 3-
4nm.  The optical micrographs of crystals obtained on this surface are shown in Figure 3(a).  At similar 
time no crystals were observed on any other surfaces.  All porous and control non-porous surface 
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resulted in crystals of lysozyme within 7 days of experimental observation. 
Thaumatin: First crystals of thaumatin were observed within 18-24 hours only on the surface with pore 
diameter 3-4nm (Figure 3(b)). At this same time no crystal were observed on any other surfaces. All 
porous surfaces yielded some crystals within 15 days. No crystals were observed on the non-porous 
control surface.     
Trypsin: Crystals formed within 48-72 hours on the surfaces with a pore diameter 3-4nm.  No crystals 
on surfaces with any other pore diameter or control surfaces were observed within 15 days.   Optical 
micrographs of the crystals obtained on surfaces with pore diameter 3-4nm are shown in Figure 3(c).    
Human Serum Albumin (HSA): Crystals formed within 36-48 hours on the surface with 6-8nm pore 
diameters.  Crystals were observed after 5 days on the surface with 3-4nm pores. All other surfaces 
(porous and non-porous control) exhibited no crystal for the full 15 days.  HSA has not been previously 
crystallized on any other porous surfaces. 
Concanavalin A -Type IV:  Diffraction quality crystals of concanavalin A were only obtained on the 
nucleants with pore diameter 10-12nm within 24-36 hours. The results of the same are reported in 
Figure 3(d).   Uncontrolled showers of crystals were observed on the surface with pore diameter 3-4nm 
after 48 hours.  These crystals were found to be of poor diffraction quality. No crystals on surfaces with 
any other pore diameter or control surfaces were observed within 15 days. Concanavalin A is a tetramer 
and all other previous attempts to crystallize it on porous nucleants with broad pore size distributions 
have failed to yield crystals16.  
Catalase: Crystals were only observed on the surface having pore diameter 10–12nm within 48-72 
hours (Figure 3(e)). No crystals on surfaces with any other pore diameter or control surfaces were 
observed within 15 days.  Catalase, which is a tetramer having molecular weight ∼10× higher than 
thaumatin is relatively large molecule, which molecularly imprinted polymers fail to crystallize24. 
Ferritin: Ferritin crystals were observed on the surfaces with pore diameter 17-21nm within 48-60 
hours (Figure 3(f)). No crystals were observed on any other surfaces at the similar time scale.  Showers 
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of very small crystals were observed on surfaces with pore diameter 13-15nm within 72 hours.  No other 
surfaces resulted in crystals within 15 days of experimental observation.  Ferritin is an iron storing 
protein, having 24 subunits and approximately double the molecular weight compared to catalase, has 
not been previously crystallized using any other porous hetronuclei.   
Proteins with lower molecular weights in the range of 14 -24kDa were successfully crystallized on the 
nucleant surfaces with the pore diameter 3-4nm, whereas the two proteins having higher molecular 
weights, in the range of 106-232kDa, were only crystallized on surface with pore diameter 10-12nm. 
Human serum albumin, which has a molecular weight 67kDa crystallized on the surface with 
intermediate pore diameter of 6-8nm, whereas no crystals were observed on the bare glass slide or all 
other templates with any other porosity for all the proteins at similar timescale.  Ferritin (450kDa), which 
is having approximately double molecular weight compared to catalase, was observed to be crystallized 
only on the surfaces having pore diameter 17-21nm.  Furthermore, the induction times measured for first 
obtaining crystals on these surfaces are 10-75% shorter compared to those reported in the published 
literature for any other porous substrates or heterogeneous nucleants under comparable crystallization 
conditions7,10,11.  
A key observation of the current study is the preferential crystallization of proteins on specifically 
engineered surfaces with controlled pore diameter and narrow pore size distribution.  The extent of this 
preferential behavior varied from being fully selective in that some proteins only crystallized on one 
template, independent of the time frame observed. In other cases crystallization occurred on one 
template initially, with other templates seeing crystallization at much later timeframes. Such substrate 
selectivity in the heterogeneous crystallization of proteins has not been previously reported. 
Heterogeneous nucleation does not crucially affect the nucleation process under higher supersaturation 
conditions33. To isolate the effects of specific pore diameter, crystallization was performed under lower 
protein concentrations than those reported as metastable conditions, whilst maintaining all other 
crystallization conditions.  Crystallization was observed to occur at significantly lower protein 
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concentrations than reported for any other porous hetero-nuclei2,16,24.  Details of the protein 
concentration for crystallization are listed in Table 3. 
Though previous work has highlighted the potential role of mesoporous materials in protein 
nucleation, the results obtained have been variable. For example, previous efforts to crystallize proteins 
on zeolites and other related materials based ordered micro/mesoporous substrates with narrow pore size 
distribution have failed16,24.  Similar studies with disordered mesoporous materials were more successful 
but could not crystallize Concanavalin A which was crystallized here successfully using a specifically 
engineered mesoporous substrate; the Type-IV nucleant16. 
The metastable conditions for heterogeneous crystallization of proteins reported in the literature were 
used as the starting point in the current work2,16,34.  To isolate the influence of the surface porosity on 
controlling nucleation, several experimental controls were performed : (i) droplets of the same protein 
trial were prepared from the same and different batches of protein and precipitant solutions, (ii)  
mesoporous surfaces used were from the same and different batches of synthesis experiments, surfaces 
were cleaned and degassed before use, (iii) before inverting the slide,  all the droplets are kept in open 
air for approximately similar time.  (iv)  All results presented here were repeated (n=5) to confirm data 
reproducibility and reliability. 
 
Discussion: 
It is postulated that protein molecules from the dilute solution enter the nano-pores via a combination 
of diffusion and capillary action.  The localized immobilization of the molecules within the optimum 
pore will effectively increase local supersaturation and thus drive forward the process of nucleus 
formation21,35. Although this mechanism represents a macroscopic explanation, the assumptions in the 
development of the classical framework oversimplify the process and limit its applicability in 
interpreting experimental findings36. 
A more comprehensive explanation of the macromolecular crystallization can be provided by the two 
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step nucleation mechanism. Here the formation of crystals from dilute solution follows the path in which 
an initial formation of a dense liquid phase occurs from the dilute liquid (difference in concentration) 
and from this dense liquid phase, due to increase in local supersaturation, the critical nucleus forms 
within the dense phase (structural change)37-39. The nucleants used in the current work are silica based 
materials, which exhibit weak attractive interactions towards the proteins under investigation, within the 
crystallization conditions used here.  Due to these attractive interactions, the formation of a highly dense 
liquid phase, which is rich in solute, should be facilitated by the hydrophilic surface chemistry. The 
concentration difference can be a factor which distinguishes between the dilute solution and highly dense 
phase. Formation of such a high density phase has been observed and characterized using light scattering 
based techniques40,41.   
At such higher supersaturation, surface porosity plays a significant role in not only inducing 
nucleation, but also in the stabilization of the nucleus formed. Considering the Gibbs Thompson 
expression, the critical nucleus size is an inverse function of supersaturation, hence the critical nucleus 
size required to induce nucleation at such high supersaturation is postulated to be minimum42.  The 
macromolecules in the highly dense phase near to the surface enter the pores under atmospheric pressure 
via capillary rise.  Once the protein molecules have entered in the pores, the local immobilization of the 
macromolecule within the pore is thought to reduce free energy barrier required for formation of 
nucleus. Proteins and other biological macromolecules, have flexible domains and the shape of 
molecules are also not spherical, hence the diameter of gyration is thought to provide a more realistic 
picture as compared to the critical nucleus size, which is also very difficult to determine at 
supersaturation for nucleation43.  When the pore diameter is slightly larger in size than the diameter of 
gyration of macromolecule, induction and stabilization of the nucleus occurs.  The diameter of gyration 
(DG= 2×Rg) reported for the proteins crystallized in the present study (under similar conditions agree) 
with this mechanism proposed44-48. The diameter of gyration of the protein and the template average pore 
diameters are shown as function of protein molecular weight in Figure 4. 
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Another rationalization of our nucleation observations can be described based on the entropic 
implications of protein nano-confinement. A nanoscale mechanism of nucleation is supported by recent 
theoretical studies which have highlighted unique protein solution behavior when confined or restricted 
to nanometer dimensional spaces. These studies provide for the first time a theoretical framework which 
may help explain why mesoporous solids with controlled pore diameter, as reported here, are especially 
successful in achieving solution thermodynamic stability, which may lead to energetically favorable 
environment for the protein folding and nucleation. Wu et al. have reported that proteins constrained 
within nano-size cylinders exhibited much higher rates of protein folding and improved thermodynamic 
stability as reflected in the folding temperatures25. These enhanced folding rates are driven by the 
geometrical restrictions in the conformation space (i.e. entropic) for the protein molecule, with protein 
stability increasing as the pore diameter decreased and approached twice the Rg for the protein in 
question. They also concluded that pore height and diameter also play a role in determining folding rates, 
though the effects of pore height have not been addressed in the current study. This work also 
acknowledges the existence of nanometer channels in some natural systems such as ribosome tunnels 
and chaperonin protein cavities, and that these natural mesoporous structures could well have a key role 
in facilitating protein folding.  Zhang and Cheung have modeled protein confinement in spherical and 
ellipsoidal nano-spaces26. For confinements spaces >5 x Rg, protein stability was comparable to that of 
the bulk solution space.  Enhanced levels of protein folding and protein thermodynamic stability, with 
folding temperatures increased by 70K, were reported for pores sizes equal to 2 x Rg compared to the 
bulk conditions, assuming repulsive interactions between the pore wall and the protein. They argue that 
an optimally engineered confinement will lower the energy barrier of transitions states in the free energy 
reaction co-ordinate space. Mittal and Best have also modeled protein confinement and have produced a 
number of scaling laws for protein stability versus confining dimensions27. Again best conditions for 
stability and folding occur as confinement dimensions approaches twice the protein’s Rg.  The 
relationship between protein confinement in nano-cavities and protein nucleation phenomena is a new 
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topic which is not yet fully understood. According to Zhang and Cheung these enhancements can be 
ascribed to the reduction in the activation energy for the relevant transition state. These authors argue 
that as the pore shape and size approaches that of the size and shape of the proteins transition state, then 
the restriction in conformations possible facilitates thermodynamically the most stable and favorable 
state for nucleation26.  
From the data experimentally reported here, it is clear that number of protein molecules within a 
critical nucleus for the experimental conditions reported here must be a minimum based on close 
relationship between pore diameter and Rg for all of the proteins reported here. Such small critical nuclei 
are especially interesting as every molecule can be the precursor for the crystalline phase, and that their 
subsequent growth into dimers, and ultimately a crystal, occurs with a free energy gain38,49.  Indeed the 
energy barrier for the creation of such a crystalline phase is available within the inherent thermal energy 
possessed by the molecules. From Table 3 it can be seen that a number of the species crystallized in the 
current study have been crystallized at lower concentrations than previously reported. Such an 
observation is consistent with the existence of lower than normal energy barriers to nuclei formation 
which could be due to a minimum critical nucleus size being achieved using the engineered mesoporous 
substrates used here. 
 
Conclusion: 
In summary, contrary to all previous reports, it is demonstrated here for the first time that surfaces 
with specific pore diameters and narrow pore size distributions, are highly effective at inducing the 
crystallization of specific protein molecules. Crystallization of proteins was found to be strongly 
dependent on pore size, with a direct correlation with protein radius of gyration. This selectivity in 
crystallization is argued to be direct consequence of local immobilization of protein molecules, which 
varies in radius of gyration, within nano-confinement and ultimately formation and stabilization of 
nucleus within the pores of specific size. Additionally, this is the only known experimental study to 
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report the successful crystallization of Concanavalin A, HSA and Ferritin on porous substrates. The 
success can be attributed to a specific surface pore size suitable to induce nucleation. Furthermore, the 
crystals are obtained at lower protein concentration and induction time as compared to one reported in 
the literature using the surfaces with specific porosity.   
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Figure 1 Pore size distribution of monoliths produced with different sacrificial templates. 
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Figure 2 Transmission Electron Micrographs of (a) Type – II (scale bar 20nm) (b) Type – III (scale bar 
20nm) (c) Type – IV (scale bar 50nm) (d) Type – V (scale bar 50nm) mesoporous templates. 
(a) (b) (c) d
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Figure 3  Crystallization of proteins on mesoporous glass surface (a)  Lysozyme crystals on surface 
with 3 – 4 nm pore diameter   (b) Thaumatin crystals on surface with 3 – 4 nm pore diameter (c) Trypsin 
crystals on surface with pore diameter 3 – 4nm (d) Concanavalin A crystals obtained on surface with 
pore diameter 10 – 12 nm (e) Catalase crystals obtained on surface with pore diameter 10 – 12nm (f) 
Ferritin crystals obtained on surface with pore diameter 17 – 21nm  (Scale bar: 200µm) (Note:  Solution 
remained clear on the rest of the surfaces at same time) 
 
(a) (b) 
(c) (d) (e) (f) 
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Figure 4 Schematic illustration of behavior of crystallization solution in presence of nucleant surface 
having narrow pore size distribution.  Radius of gyration details is referred from the literature44-48.  
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Tables: 
 
 
Table 1 Physical properties of mesoporous glass prepared with different sacrificial templates. 
Type of Sample Surface area 
(m2 g−1) 
Total pore volume 
(cm3 g−1) 
Average pore diameter 
(nm) 
Type-I 658.3 0.531 4.02 
Type-II 534.1 0.584 5.69 
Type-III 438.2 0.931 10.76 
Type-IV 398.5 0.982 13.12 
Type –V 299.3 1.063 20.07 
 
 
23 
 
Table 2 Details of crystallization results obtained at metastable conditions reported in the literature. 
 
Protein 
(Molecular 
Weight, kDa) 
Control 
(Non-Porous) 
Pore diameter 
(3-4nm) 
Pore diameter 
(6-8nm) 
Pore diameter 
(10-12nm) 
Pore diameter 
(13-15nm) 
Pore diameter  
(17-21nm) 
Lysozyme 
(14) 
uncontrolled 
crystallization 
Well faceted 
crystals 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
Thaumatin 
(22) 
no crystals well faceted 
crystals 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
uncontrolled 
crystallization 
Trypsin (24) no crystals well faceted 
crystals 
no crystals no crystals no crystals no crystals 
Human 
Serum 
Albumin (67) 
no crystals no crystals crystals no crystals no crystals no crystals 
Concanavalin 
A (106) 
no crystals uncontrolled 
crystallization 
no crystals well faceted 
crystals 
no crystals no crystals 
Catalase 
(232) 
no crystals no crystals no crystals well faceted 
crystals 
no crystals no crystals 
Ferritin (450) no crystals no crystals no crystals no crystals uncontrolled 
crystallization 
well faceted 
crystals 
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Table 3 Comparison of protein concentrations reported for crystallization on porous and non-porous 
hetero-nuclei under similar conditions compared with current mesoporous glasses (Data in column 3 
and 4 are the lowest protein concentrations reported for crystals appearance on the relevant nucleant 
surfaces). 
Protein  
(MW, kDa) 
Protein 
Concentration 
(mesoporous glass-
present work) 
Protein Concentration. 
(porous heteronuclei) 
Protein Concentration. 
(non-porous heteronuclei) 
Lysozyme (14) 5.0 mg/ml 15.0 mg/ml16 5.0 mg/ml7 
Thaumatin (22) 2.0 mg/ ml 16.0 mg/ml16 2.0 mg/ml*7 
Trypsin (24) 11.5 mg/ml 12.0 mg/ml16 No Comparable data 
available** 
Human Serum 
Albumin (67) 
75.0 mg/ml No data available 255.0 mg/ml11 
Concanavalin A (106) 2.0 mg/ml No data available 5.0 mg/ml*7 
Catalase (232) 6.0 mg/ml 11.5 mg/ml16 No Comparable data 
available** 
Ferritin (450) 1.0 mg/ml No data available No Comparable data 
available** 
 
*Crystallization was carried out at higher precipitant concentration as compared to the same used in 
this study. 
** Different salt and buffer conditions were used for crystallization in different literature. No 
comparable data is available for discussion. 
 
 
 
25 
 
Table 4 Conditions under which the proteins are crystallized in the presence of mesoporous glasses. 
 
Name of Protein Buffer Solution 
(Solvent water) 
Precipitant Solution Final Protein C 
(mg/ml) 
Lysozyme 20 mM Acetate 
buffer, pH 4.8  
 
0.5-1M NaCl 5.0 – 15.0 
Thaumatin  50 mM PIPES  
pH 6.8 
340 mM  
Na- K Tartrate 
2.0 – 11.5 
Trypsin  
 
100 mM Tris  
pH 8.4 
30-32%  (w/v) 
(NH4)2SO4  
11.5 – 12.0 
Human Serum 
Albumin  
50mM Mono-
potassium 
Phosphate pH 5.15 
5% (w/v) PEG 4K 75.0 – 255.0 
Concanavalin A 
 
10 mM Tris pH 8.5;  
20 mM CaCl2;  
20 mM MnCl2  
1M (NH4)2SO4 in 20 
mm Tris pH 8.0  
2.0 – 17.5 
Catalase 
 
100 mM Tris pH 8.4  5% (w/v) PEG 4K;  
5% (v/v) 2-Methyl-1,3 
Propanediol (MPD)  
6.0 – 11.5 
Ferritin 200 mM Acetate 
buffer, pH 5.0  
 
1.6% CdSO4  
 
1.0 – 2.8 
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Synopsis: Surface selective crystallization of proteins on engineered nanoporous surfaces with narrow 
pore size distribution is reported here for the first time.  Using engineered nanonucleants, crystallization 
was observed to be faster and at lower protein concentration. Systematic approach for controlling 
heterogeneous nucleation of proteins based on a relationship between protein radius of gyration and 
specific nucleant pore dimensions is proposed.   
